Nasdaq
End-of-day closes; the latest point is the live 15-min-delayed price · split & dividend adjusted · chart by TradingView
Firefly Neuroscience, Inc., a medical technology and artificial intelligence company, provides neuroscientific solutions that improve outcomes for patients with mental illnesses and neurological disorders. The company offers Brain Network Analytics, a software that focuses on diagnostic and treatment for people suffering from mental illnesses and cognitive disorders, including depression, dementia, anxiety disorders, concussions, and attention-deficit/hyperactivity disorder. It serves pharmaceutical companies and medical practitioners. Firefly Neuroscience, Inc. is based in Toronto, Canada.
Roles derived from SEC Form 4 filings.
Actuals from SEC filings; YoY vs the year-ago quarter. Analyst estimates & surprise require a data feed (coming soon).
| Line item | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|
| Revenue | $13.9M | $15.0M | $12.0M | $498,000.00 | $108,000.00 | $1.1M |
| Gross profit | $2.2M | $3.6M | $2.9M | $2.6M | $108,000.00 | $645,000.00 |
| Operating income | $411,848.00 | -$2.6M | -$5.4M | -$3.1M | -$10.1M | -$8.9M |
| Net income | $413,379.00 | -$1.1M | -$17.8M | -$2.6M | -$10.5M | -$19.9M |
| Diluted EPS | $0.03 | -$0.09 | — | — | — | — |
| Operating cash flow | $423,265.00 | -$735,015.00 | -$6.0M | -$2.2M | -$6.2M | -$8.2M |
| Free cash flow | $358,718.00 | -$804,769.00 | -$6.5M | -$2.2M | — | — |
| Gross margin | 15.9% | 24.1% | 23.8% | 525.0% | 100.0% | 56.5% |
| Operating margin | 3.0% | -17.5% | -45.1% | -618.1% | -9309.3% | -775.5% |
| Net margin | 3.0% | -7.5% | -147.7% | -522.7% | -9685.2% | -1741.0% |
| Line item | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $10,000.00 | $33,000.00 | $53,000.00 | $43,000.00 | $299,000.00 | $388,000.00 | $412,000.00 | $485,000.00 |
| Gross profit | $10,000.00 | $33,000.00 | -$634,258.00 | $43,000.00 | $274,000.00 | $146,000.00 | $182,000.00 | $221,000.00 |
| Operating income | -$1.3M | -$4.3M | -$3.4M | -$2.1M | -$1.6M | -$2.7M | -$2.5M | -$2.0M |
| Net income | -$1.3M | -$4.3M | -$3.8M | -$12.9M | -$1.8M | -$2.6M | -$2.5M | -$2.0M |
| Diluted EPS | -$0.58 | -$0.61 | — | — | — | -$0.20 | — | — |
| Operating cash flow | -$1.1M | -$2.5M | -$1.2M | -$2.5M | -$2.4M | -$1.5M | -$1.8M | -$1.9M |
| Free cash flow | — | — | — | — | — | — | — | — |
| Gross margin | 100.0% | 100.0% | -1196.7% | 100.0% | 91.6% | 37.6% | 44.2% | 45.6% |
| Operating margin | -12590.0% | -12933.3% | -6483.0% | -4802.3% | -546.5% | -684.5% | -607.0% | -414.4% |
| Net margin | -12640.0% | -12997.0% | -7141.5% | -30069.8% | -613.0% | -680.2% | -601.9% | -413.2% |
Consensus revenue & EPS estimates and price targets will appear here once a forward-estimates data feed is connected.
| Date | Insider | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|
| 2026-03-10 | DeCaprio David· President and COO | Award | 44,872 | $0.00 | $0.00 | filing |
| 2026-03-10 | Lipschitz Gregory· Chief Executive Officer | Award | 65,988 | $0.00 | $0.00 | filing |
| 2025-10-22 | Windsor Private Capital LP | Sale | 78,031 | $2.07 | $161,734.85 | filing |
| 2025-10-21 | Windsor Private Capital LP | Sale | 19,222 | $2.40 | $46,140.49 | filing |
| 2025-10-20 | Windsor Private Capital LP | Sale | 33,500 | $2.46 | $82,309.50 | filing |
| 2025-10-17 | Windsor Private Capital LP | Sale | 45,036 | $2.55 | $114,670.66 | filing |
| 2025-10-16 | Windsor Private Capital LP | Sale | 40,139 | $2.65 | $106,456.66 | filing |
| 2025-10-15 | Windsor Private Capital LP | Sale | 17,500 | $2.74 | $48,027.00 | filing |
| 2025-10-14 | Windsor Private Capital LP | Sale | 29,500 | $2.74 | $80,800.50 | filing |
| 2025-10-13 | Windsor Private Capital LP | Sale | 32,136 | $2.65 | $85,240.74 | filing |
| 2025-10-10 | Windsor Private Capital LP | Sale | 74,810 | $2.70 | $201,942.11 | filing |
| 2025-10-09 | Windsor Private Capital LP | Sale | 30,126 | $2.94 | $88,693.96 | filing |
Latest 12 transactions.
Fundamentals & filings from SEC EDGAR. Prices adjusted for splits & dividends. Not investment advice.